Last 12 months
Inside the activity.
0 purchase rows · 48 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 5 |
| Mar 2026 | 0 | 12 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 26, 2024 Filed Nov 27, 2024 22:38 UTC |
Lalwani NikhilDirector · PRESIDENT & CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 30,000 | $29.00 Strike: $29.00 | $870,000.00 |
DisclosureSEC source: 0001822629-24-000014 · wk-form4_1732747122.xml · derivative · entry 4 Lalwani Nikhil · CIK 0001822629 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,027 Underlying: Common Stock · 30,000 shares Expires 2030-09-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the total options vested on each of September 8, 2021, September 8, 2022, September 8, 2023 and September 8, 2024. Read SEC document |
| November 26, 2024 Filed Nov 27, 2024 22:38 UTC |
Lalwani NikhilDirector · PRESIDENT & CEO
|
SaleCommon Stock | 3,481 | $58.30 | $202,942.30 |
DisclosureSEC source: 0001822629-24-000014 · wk-form4_1732747122.xml · nonDerivative · entry 3 Lalwani Nikhil · CIK 0001822629 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 370,378 F2 · price: The shares were sold in multiple trades at prices ranging from $58.18 to $58.61. The price reported above reflects the weighted average sales price. Read SEC document |
| November 26, 2024 Filed Nov 27, 2024 22:38 UTC |
Lalwani NikhilDirector · PRESIDENT & CEO
|
SaleCommon Stock | 30,000 | $57.95 | $1,738,500.00 |
DisclosureSEC source: 0001822629-24-000014 · wk-form4_1732747122.xml · nonDerivative · entry 2 Lalwani Nikhil · CIK 0001822629 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 373,859 F1 · price: The shares were sold in multiple trades at prices ranging from $57.76 to $58.55. The price reported above reflects the weighted average sales price. Read SEC document |
| November 26, 2024 Filed Nov 27, 2024 22:38 UTC |
Lalwani NikhilDirector · PRESIDENT & CEO
|
Exercise / conversionCommon Stock | 30,000 | $29.00 | $870,000.00 |
DisclosureSEC source: 0001822629-24-000014 · wk-form4_1732747122.xml · nonDerivative · entry 1 Lalwani Nikhil · CIK 0001822629 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 403,859 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2024 Filed Nov 18, 2024 21:05 UTC |
Rowland Thomas AndrewSVP, HEAD - ESTABLISHED BRANDS
|
Tax withholdingCommon Stock | 867 | $56.58 | $49,054.86 |
DisclosureSEC source: 0001507496-24-000006 · wk-form4_1731963909.xml · nonDerivative · entry 1 Rowland Thomas Andrew · CIK 0001507496 · SVP, HEAD - ESTABLISHED BRANDS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,169 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,000 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| November 15, 2024 Filed Nov 18, 2024 21:03 UTC |
Mutz ChristopherHEAD OF RARE DISEASE
|
SaleCommon Stock | 6,500 | $57.70 | $375,050.00 |
DisclosureSEC source: 0001846487-24-000014 · wk-form4_1731963799.xml · nonDerivative · entry 1 Mutz Christopher · CIK 0001846487 · HEAD OF RARE DISEASE 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,777 Read SEC document |
| November 13, 2024 Filed Nov 14, 2024 21:16 UTC |
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
|
SaleCommon Stock | 250 | $61.36 | $15,340.00 |
DisclosureSEC source: 0001938861-24-000030 · wk-form4_1731618972.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,238 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2023. Read SEC document |
| October 14, 2024 Filed Oct 15, 2024 21:57 UTC |
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
|
SaleCommon Stock | 250 | $57.19 | $14,297.50 |
DisclosureSEC source: 0001938861-24-000028 · wk-form4_1729029460.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,488 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2023. Read SEC document |
| September 13, 2024 Filed Sep 16, 2024 20:50 UTC |
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
|
SaleCommon Stock | 250 | $56.82 | $14,205.00 |
DisclosureSEC source: 0001938861-24-000026 · wk-form4_1726519846.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,738 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2023. Read SEC document |
| September 12, 2024 Filed Sep 13, 2024 20:23 UTC |
Davis KristaSVP, CHIEF HR OFFICER
|
Tax withholdingCommon Stock | 1,486 | $56.15 | $83,438.90 |
DisclosureSEC source: 0001946439-24-000006 · wk-form4_1726258989.xml · nonDerivative · entry 1 Davis Krista · CIK 0001946439 · SVP, CHIEF HR OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,059 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,108 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| September 08, 2024 Filed Sep 10, 2024 20:44 UTC |
Lalwani NikhilDirector · PRESIDENT & CEO
|
Tax withholdingCommon Stock | 3,646 | $60.51 | $220,619.46 |
DisclosureSEC source: 0001822629-24-000012 · wk-form4_1726001072.xml · nonDerivative · entry 1 Lalwani Nikhil · CIK 0001822629 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 373,859 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 7,127 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| August 13, 2024 Filed Aug 14, 2024 12:29 UTC |
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
|
SaleCommon Stock | 250 | $59.62 | $14,905.00 |
DisclosureSEC source: 0001938861-24-000023 · wk-form4_1723638583.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,988 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2023. Read SEC document |
| July 18, 2024 Filed Jul 19, 2024 21:30 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 2,743 | $62.00 | $170,066.00 |
DisclosureSEC source: 0001870913-24-000028 · wk-form4_1721424608.xml · nonDerivative · entry 2 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 632,620 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023. F2 · price: The shares were sold in multiple trades at prices ranging from $61.01 to $62.92. The price reported above reflects the weighted average sales price. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| July 18, 2024 Filed Jul 19, 2024 21:27 UTC |
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
|
Tax withholdingCommon Stock | 1,743 | $61.35 | $106,933.05 |
DisclosureSEC source: 0001938861-24-000020 · wk-form4_1721424440.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,238 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,820 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| July 17, 2024 Filed Jul 17, 2024 23:07 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 14,257 | $63.16 | $900,472.12 |
DisclosureSEC source: 0001870913-24-000026 · wk-form4_1721257659.xml · nonDerivative · entry 4 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 635,363 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023. F5 · price: The shares were sold in multiple trades at prices ranging from $62.62 to $64.21. The price reported above reflects the weighted average sales price. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| July 16, 2024 Filed Jul 17, 2024 23:07 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 22,000 | $64.27 | $1,413,940.00 |
DisclosureSEC source: 0001870913-24-000026 · wk-form4_1721257659.xml · nonDerivative · entry 3 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 649,620 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023. F4 · price: The shares were sold in multiple trades at prices ranging from $63.25 to $64.91. The price reported above reflects the weighted average sales price. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| July 15, 2024 Filed Jul 17, 2024 23:07 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 11,000 | $63.38 | $697,180.00 |
DisclosureSEC source: 0001870913-24-000026 · wk-form4_1721257659.xml · nonDerivative · entry 2 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 671,620 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023. F2 · price: The shares were sold in multiple trades at prices ranging from $62.47 to $64.19. The price reported above reflects the weighted average sales price. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| July 12, 2024 Filed Jul 15, 2024 20:38 UTC |
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
|
SaleCommon Stock | 250 | $64.91 | $16,227.50 |
DisclosureSEC source: 0001938861-24-000018 · wk-form4_1721075886.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,981 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2023. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 00:58 UTC |
Gassert ChadSVP - CORP. DEV. & STRATEGY
|
SaleCommon Stock | 20,000 | $63.44 | $1,268,800.00 |
DisclosureSEC source: 0001871002-24-000014 · wk-form4_1719968317.xml · nonDerivative · entry 2 Gassert Chad · CIK 0001871002 · SVP - CORP. DEV. & STRATEGY 10b5-1 filing: Plan reported Ownership: Indirect · Held by Chali Properties LLC Disclosed balance after: 193,226 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2023. F2 · price: The shares were sold in multiple trades at prices ranging from $62.81 to $64.11. The price reported above reflects the weighted average sales price. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC. Read SEC document |
| June 21, 2024 Filed Jun 24, 2024 20:12 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 20,000 | $58.90 | $1,178,000.00 |
DisclosureSEC source: 0001870913-24-000024 · wk-form4_1719259916.xml · nonDerivative · entry 2 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 682,620 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023. F2 · price: The shares were sold in multiple trades at prices ranging from $58.43 to $59.48. The price reported above reflects the weighted average sales price. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| June 20, 2024 Filed Jun 20, 2024 23:11 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 11,447 | $59.86 | $685,217.42 |
DisclosureSEC source: 0001870913-24-000022 · wk-form4_1718925060.xml · nonDerivative · entry 4 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 702,620 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023. F5 · price: The shares were sold in multiple trades at prices ranging from $59.40 to $60.50. The price reported above reflects the weighted average sales price. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| June 18, 2024 Filed Jun 20, 2024 23:11 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 10,607 | $60.76 | $644,481.32 |
DisclosureSEC source: 0001870913-24-000022 · wk-form4_1718925060.xml · nonDerivative · entry 3 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 714,067 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023. F4 · price: The shares were sold in multiple trades at prices ranging from $60.33 to $61.82. The price reported above reflects the weighted average sales price. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| June 17, 2024 Filed Jun 20, 2024 23:11 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 7,946 | $61.41 | $487,963.86 |
DisclosureSEC source: 0001870913-24-000022 · wk-form4_1718925060.xml · nonDerivative · entry 2 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 724,674 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023. F2 · price: The shares were sold in multiple trades at prices ranging from $60.77 to $62.55. The price reported above reflects the weighted average sales price. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| June 13, 2024 Filed Jun 14, 2024 21:23 UTC |
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
|
SaleCommon Stock | 250 | $63.80 | $15,950.00 |
DisclosureSEC source: 0001938861-24-000016 · wk-form4_1718400226.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 59,231 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2023. Read SEC document |
| June 07, 2024 Filed Jun 11, 2024 20:51 UTC |
Marken James G.SVP OPS & PROD DEV
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,300 | $57.06 Strike: $57.06 | $302,418.00 |
DisclosureSEC source: 0001579587-24-000013 · wk-form4_1718139096.xml · derivative · entry 5 Marken James G. · CIK 0001579587 · SVP OPS & PROD DEV 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,300 shares Expires 2028-04-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the total options vested on each of April 6, 2019, April 6, 2020, April 6, 2021, and April 6, 2022. Read SEC document |
| June 07, 2024 Filed Jun 11, 2024 20:51 UTC |
Marken James G.SVP OPS & PROD DEV
|
Exercise / conversionStock Option (right to buy) · Derivative | 7,250 | $49.51 Strike: $49.51 | $358,947.50 |
DisclosureSEC source: 0001579587-24-000013 · wk-form4_1718139096.xml · derivative · entry 4 Marken James G. · CIK 0001579587 · SVP OPS & PROD DEV 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,250 shares Expires 2027-03-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the total options vested on each of March 31, 2018, March 31, 2019, March 31, 2020, and March 31, 2021. Read SEC document |
| June 07, 2024 Filed Jun 11, 2024 20:51 UTC |
Marken James G.SVP OPS & PROD DEV
|
Tax withholdingCommon Stock | 11,087 | $67.70 | $750,589.90 |
DisclosureSEC source: 0001579587-24-000013 · wk-form4_1718139096.xml · nonDerivative · entry 3 Marken James G. · CIK 0001579587 · SVP OPS & PROD DEV 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,829 F2 · price: The shares were sold in multiple trades at prices ranging from $67.64 to $68.10. The price reported above reflects the weighted average sales price. Read SEC document |
| June 07, 2024 Filed Jun 11, 2024 20:51 UTC |
Marken James G.SVP OPS & PROD DEV
|
Exercise / conversionCommon Stock | 5,300 | $57.06 | $302,418.00 |
DisclosureSEC source: 0001579587-24-000013 · wk-form4_1718139096.xml · nonDerivative · entry 2 Marken James G. · CIK 0001579587 · SVP OPS & PROD DEV 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,916 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 07, 2024 Filed Jun 11, 2024 20:51 UTC |
Marken James G.SVP OPS & PROD DEV
|
Exercise / conversionCommon Stock | 7,250 | $49.51 | $358,947.50 |
DisclosureSEC source: 0001579587-24-000013 · wk-form4_1718139096.xml · nonDerivative · entry 1 Marken James G. · CIK 0001579587 · SVP OPS & PROD DEV 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,616 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The number of shares beneficially owned by the reporting person is amended in this Form 4 to correct an administrative error in a Form 4 filed on March 9, 2023, which misreported that 1,951 shares were withheld on March 7, 2023 to cover taxes on a vesting of shares on that date, when 1,591 shares were withheld. In correcting this administrative error, the number of shares beneficially owned by the reporting person reflects an increase of 360 shares. Read SEC document |
| June 05, 2024 Filed Jun 6, 2024 22:21 UTC |
Gutwerg OriSVP, GENERICS
|
SaleCommon Stock | 2,985 | $67.00 | $199,995.00 |
DisclosureSEC source: 0001846478-24-000011 · wk-form4_1717712497.xml · nonDerivative · entry 1 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,227 Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 11:34 UTC |
CAREY STEPHEN P.SVP & CFO
|
SaleCommon Stock | 5,000 | $63.58 | $317,900.00 |
DisclosureSEC source: 0001674236-24-000013 · wk-form4_1717673646.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 161,968 F1 · price: The shares were sold in multiple trades at prices ranging from $64.85 to $62.72. The price reported above reflects the weighted average sales price. Read SEC document |
| June 03, 2024 Filed Jun 4, 2024 22:08 UTC |
Gassert ChadSVP - CORP. DEV. & STRATEGY
|
SaleCommon Stock | 20,000 | $64.41 | $1,288,200.00 |
DisclosureSEC source: 0001871002-24-000012 · wk-form4_1717538875.xml · nonDerivative · entry 2 Gassert Chad · CIK 0001871002 · SVP - CORP. DEV. & STRATEGY 10b5-1 filing: Plan reported Ownership: Indirect · Held by Chali Properties LLC Disclosed balance after: 213,226 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2023. F2 · price: The shares were sold in multiple trades at prices ranging from $63.35 to $65.40. The price reported above reflects the weighted average sales price. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC. Read SEC document |
| May 21, 2024 Filed May 22, 2024 22:14 UTC |
Mutz ChristopherHEAD OF RARE DISEASE
|
SaleCommon Stock | 2,000 | $61.61 | $123,220.00 |
DisclosureSEC source: 0001846487-24-000012 · wk-form4_1716416059.xml · nonDerivative · entry 1 Mutz Christopher · CIK 0001846487 · HEAD OF RARE DISEASE 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,277 Read SEC document |
| May 21, 2024 Filed May 24, 2024 00:03 UTC |
Walsh Patrick DDirector
|
GrantCommon Stock | 4,410 | $0.00 | $0.00 |
DisclosureSEC source: 0001720568-24-000003 · wk-form4_1716509024.xml · nonDerivative · entry 1 Walsh Patrick D · CIK 0001720568 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,712 F1 · kind: Represents a restricted stock award that will vest in full on May 21, 2025. Read SEC document |
| May 21, 2024 Filed May 24, 2024 00:02 UTC |
Thoma JeanneDirector
|
GrantCommon Stock | 4,410 | $0.00 | $0.00 |
DisclosureSEC source: 0001819879-24-000002 · wk-form4_1716508923.xml · nonDerivative · entry 1 Thoma Jeanne · CIK 0001819879 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,609 F1 · kind: Represents a restricted stock award that will vest in full on May 21, 2025. Read SEC document |
| May 21, 2024 Filed May 23, 2024 23:59 UTC |
TANNENBAUM RENEE PDirector
|
GrantCommon Stock | 4,410 | $0.00 | $0.00 |
DisclosureSEC source: 0001543174-24-000005 · wk-form4_1716508769.xml · nonDerivative · entry 1 TANNENBAUM RENEE P · CIK 0001543174 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,621 F1 · kind: Represents a restricted stock award that will vest in full on May 21, 2025. Read SEC document |
| May 21, 2024 Filed May 23, 2024 23:58 UTC |
Pera Antonio RDirector
|
GrantCommon Stock | 4,410 | $0.00 | $0.00 |
DisclosureSEC source: 0001689325-24-000005 · wk-form4_1716508672.xml · nonDerivative · entry 1 Pera Antonio R · CIK 0001689325 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,037 F1 · kind: Represents a restricted stock award that will vest in full on May 21, 2025. Read SEC document |
| May 21, 2024 Filed May 23, 2024 23:54 UTC |
Leonard Matthew JDirector
|
GrantCommon Stock | 4,410 | $0.00 | $0.00 |
DisclosureSEC source: 0001773152-24-000003 · wk-form4_1716508443.xml · nonDerivative · entry 1 Leonard Matthew J · CIK 0001773152 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,993 F1 · kind: Represents a restricted stock award that will vest in full on May 21, 2025. Read SEC document |
| May 21, 2024 Filed May 23, 2024 23:45 UTC |
HAUGHEY THOMASDirector
|
GrantCommon Stock | 4,410 | $0.00 | $0.00 |
DisclosureSEC source: 0001272247-24-000003 · wk-form4_1716507934.xml · nonDerivative · entry 1 HAUGHEY THOMAS · CIK 0001272247 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,526 F1 · kind: Represents a restricted stock award that will vest in full on May 21, 2025. Read SEC document |
| May 20, 2024 Filed May 21, 2024 21:21 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 12,855 | $61.81 | $794,567.55 |
DisclosureSEC source: 0001870913-24-000020 · wk-form4_1716326500.xml · nonDerivative · entry 2 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 732,620 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023. F2 · price: The shares were sold in multiple trades at prices ranging from $61.44 to $62.36. The price reported above reflects the weighted average sales price. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| May 17, 2024 Filed May 17, 2024 22:05 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 5,836 | $62.09 | $362,357.24 |
DisclosureSEC source: 0001870913-24-000018 · wk-form4_1715983489.xml · nonDerivative · entry 4 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 745,475 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023. F5 · price: The shares were sold in multiple trades at prices ranging from $61.43 to $64.00. The price reported above reflects the weighted average sales price. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| May 16, 2024 Filed May 17, 2024 22:05 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 16,459 | $63.84 | $1,050,742.56 |
DisclosureSEC source: 0001870913-24-000018 · wk-form4_1715983489.xml · nonDerivative · entry 3 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 751,311 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023. F4 · price: The shares were sold in multiple trades at prices ranging from $63.28 to $64.90. The price reported above reflects the weighted average sales price. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| May 16, 2024 Filed May 17, 2024 22:01 UTC |
TANNENBAUM RENEE PDirector
|
SaleCommon Stock | 2,000 | $63.87 | $127,740.00 |
DisclosureSEC source: 0001543174-24-000002 · wk-form4_1715983230.xml · nonDerivative · entry 1 TANNENBAUM RENEE P · CIK 0001543174 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,211 Read SEC document |
| May 15, 2024 Filed May 17, 2024 22:05 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 14,850 | $65.86 | $978,021.00 |
DisclosureSEC source: 0001870913-24-000018 · wk-form4_1715983489.xml · nonDerivative · entry 2 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 767,770 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023. F2 · price: The shares were sold in multiple trades at prices ranging from $64.66 to $66.54. The price reported above reflects the weighted average sales price. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| May 14, 2024 Filed May 16, 2024 21:02 UTC |
Lalwani NikhilDirector · PRESIDENT & CEO
|
SaleCommon Stock | 16,669 | $66.10 | $1,101,820.90 |
DisclosureSEC source: 0001822629-24-000010 · wk-form4_1715893316.xml · nonDerivative · entry 1 Lalwani Nikhil · CIK 0001822629 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 377,505 F1 · price: The shares were sold in multiple trades at prices ranging from $65.67 to $67.56. The price reported above reflects the weighted average sales price. Read SEC document |
| May 13, 2024 Filed May 13, 2024 21:25 UTC |
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
|
SaleCommon Stock | 250 | $67.69 | $16,922.50 |
DisclosureSEC source: 0001938861-24-000014 · wk-form4_1715635512.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 59,481 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2023. Read SEC document |
| May 01, 2024 Filed May 3, 2024 21:48 UTC |
Gassert ChadSVP - CORP. DEV. & STRATEGY
|
SaleCommon Stock | 20,000 | $66.62 | $1,332,400.00 |
DisclosureSEC source: 0001871002-24-000010 · wk-form4_1714772885.xml · nonDerivative · entry 2 Gassert Chad · CIK 0001871002 · SVP - CORP. DEV. & STRATEGY 10b5-1 filing: Plan reported Ownership: Indirect · Held by Chali Properties LLC Disclosed balance after: 233,226 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2023. F2 · price: The shares were sold in multiple trades at prices ranging from $66.05 to $67.30. The price reported above reflects the weighted average sales price. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC. Read SEC document |
| April 19, 2024 Filed Apr 22, 2024 22:26 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 16,809 | $65.17 | $1,095,442.53 |
DisclosureSEC source: 0001870913-24-000016 · wk-form4_1713824793.xml · nonDerivative · entry 3 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 782,620 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023. F4 · price: The shares were sold in multiple trades at prices ranging from $64.20 to $65.79. The price reported above reflects the weighted average sales price. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| April 18, 2024 Filed Apr 22, 2024 22:26 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 10,423 | $64.98 | $677,286.54 |
DisclosureSEC source: 0001870913-24-000016 · wk-form4_1713824793.xml · nonDerivative · entry 2 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 799,429 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023. F2 · price: The shares were sold in multiple trades at prices ranging from $64.43 to $65.89. The price reported above reflects the weighted average sales price. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| April 17, 2024 Filed Apr 17, 2024 20:33 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 9,520 | $65.40 | $622,608.00 |
DisclosureSEC source: 0001870913-24-000014 · wk-form4_1713385980.xml · nonDerivative · entry 4 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 809,852 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023. F5 · price: The shares were sold in multiple trades at prices ranging from $65.04 to $66.06. The price reported above reflects the weighted average sales price. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.